173 filings
Page 6 of 9
6-K
kau5b5 9yi53
29 Apr 20
Aptorum Group Limited Reports 2019 Fiscal Year End Financial Results and Provides Business Update
8:01am
6-K
vjc8 iui3devpoqk3vv
30 Mar 20
Report of Foreign Private Issuer
8:00am
424B5
x5xh onx0
27 Feb 20
Prospectus supplement for primary offering
5:33pm
6-K
dxy17y5pmdocps79xyq9
26 Feb 20
Alliance Global Partners
1:20pm
6-K
u8zxbbmty0nc
24 Feb 20
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong
6:02am
6-K
2hbr2m00o8typxix2
10 Feb 20
Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for Neuroblastoma Targeting IND Submission in H2 2020
8:01am
EFFECT
htnbywcxq bi1g5fs
16 Jan 20
Notice of effectiveness
12:15am
CORRESP
hdk1j4withje5qah
14 Jan 20
Correspondence with SEC
12:00am
UPLOAD
u5gccj6aayszyp72nekr
14 Jan 20
Letter from SEC
12:00am
6-K
w9tdmq01n3w w4617
13 Jan 20
Current report (foreign)
6:01am
F-3
3dk4z4j cr18v61m2
6 Jan 20
Shelf registration (foreign)
4:19pm
RW
3relvsf0
26 Dec 19
Registration withdrawal request
10:46am
F-3
p1hlns
18 Dec 19
Shelf registration (foreign)
10:19am
424B3
nrec8eb8z23 sa9c
26 Nov 19
Prospectus supplement
11:11am
EFFECT
cxfwbt0
20 Nov 19
Notice of effectiveness
12:15am
6-K
bab6n ccly0a8qist7
15 Nov 19
Aptorum Group Limited Announces Results of 2019 Annual General Meeting
9:30am
POS AM
31s 19owudggc4
12 Nov 19
Prospectus update (post-effective amendment)
4:13pm
424B3
baa9z5
31 Oct 19
Prospectus supplement
11:38am
6-K
z9j 4s3hy
25 Oct 19
Report of Foreign Private Issuer
6:04am